Active substance
Methocarbamol
- US FDA 76
- Health Canada 1
- US price lines 3
- NHS prices 3
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| ROBAXIN | 1GM/10ML (100MG/ML) | solution · im-iv | HIKMA PHARMS | Prescription | 10 Jun 1959 |
| METHOCARBAMOL | 750MG; 500MG | tablet · oral | PRINSTON INC | Prescription | 29 Oct 1979 |
| METHOCARBAMOL | 500MG; 750MG | tablet · oral | OXFORD PHARMS | Prescription | 29 Jan 2003 |
| METHOCARBAMOL | 500MG; 750MG | tablet · oral | HETERO LABS LTD III | Prescription | 6 Nov 2009 |
| METHOCARBAMOL | 500MG; 750MG; 1GM | tablet · oral | BOSTAL | Prescription | 21 Oct 2011 |
| METHOCARBAMOL | 1GM/10ML (100MG/ML) | solution · im-iv | EUGIA PHARMA | Prescription | 27 May 2016 |
| METHOCARBAMOL | 1GM/10ML (100MG/ML) | solution · im-iv | MONTEREY PHARMS LLC | Prescription | 27 Oct 2016 |
| METHOCARBAMOL | 1GM/10ML (100MG/ML) | solution · im-iv | HAINAN POLY | Prescription | 19 Jan 2017 |
| METHOCARBAMOL | 500MG; 750MG | tablet · oral | PHARMOBEDIENT | Prescription | 8 Feb 2017 |
| METHOCARBAMOL | 1GM/10ML (100MG/ML) | solution · im-iv | AM REGENT | Prescription | 22 Jun 2017 |
| METHOCARBAMOL | 1GM/10ML (100MG/ML) | solution · im-iv | SAGENT PHARMS INC | Prescription | 18 Jul 2017 |
| METHOCARBAMOL | 500MG; 750MG | tablet · oral | REGCON HOLDINGS | Prescription | 21 Jul 2017 |
| METHOCARBAMOL | 1GM/10ML (100MG/ML) | solution · im-iv | SOMERSET THERAPS LLC | Prescription | 31 Jul 2017 |
| METHOCARBAMOL | 1GM/10ML (100MG/ML) | solution · im-iv | FRESENIUS KABI USA | Prescription | 17 Apr 2018 |
| METHOCARBAMOL | 500MG; 750MG | tablet · oral | GRANULES | Prescription | 7 May 2018 |
| METHOCARBAMOL | 1GM/10ML (100MG/ML) | solution · im-iv | GLAND | Prescription | 26 Oct 2018 |
| METHOCARBAMOL | 750MG; 500MG | tablet · oral | AUROBINDO PHARMA LTD | Prescription | 12 Aug 2020 |
| METHOCARBAMOL | 500MG; 750MG | tablet · oral | POINTVIEW HLDINGS | Prescription | 30 Apr 2021 |
| METHOCARBAMOL | 1GM | tablet · oral | MIKART | Prescription | 12 Jun 2023 |
| ATMEKSI | 750MG/5ML; 750MG(5ML) | suspension · oral | ROSEMONT PHARMS | Prescription | 30 Jul 2025 |
| ROBAXIN | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | ENDO OPERATIONS | Discontinued | 16 Jul 1957 |
| ROBAXIN-750 | 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | ENDO OPERATIONS | Discontinued | 16 Jul 1957 |
| METHOCARBAMOL | 500MG | tablet · oral | PURACAP PHARM | Discontinued | 22 Oct 1974 |
| METHOCARBAMOL | 750MG | tablet · oral | PURACAP PHARM | Discontinued | 25 Feb 1975 |
| METHOCARBAMOL | 750MG | tablet · oral | SUN PHARM INDUSTRIES | Discontinued | 16 May 1975 |
51 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ROBAXIN 750 | 01932187 | 750 MG | TABLET · ORAL | HALEON CANADA ULC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | METHOCARBAMOL 1,000 MG TABLET | $8.348 | per EA | 20 May 2026 |
| US NADAC | METHOCARBAMOL 500 MG TABLET | $0.03946 | per EA | 23 Sep 2026 |
| US NADAC | METHOCARBAMOL 750 MG TABLET | $0.04311 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Methocarbamol 1500mg tablets | £19.44 | 96 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Methocarbamol 1500mg tablets | £20.25 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Methocarbamol 750mg tablets | £3.82 | 100 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Combinations containing Methocarbamol
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.